Related Experiment Video

Updated: Mar 5, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

Reply to: "Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor

Mamatha Bhat1, Peter Ghali1, Marc Bilodeau2

  • 1Department of Medicine, Division of Gastroenterology and Hepatology, McGill University, Canada.

Journal of Hepatology
|March 29, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

6.8K

Related Experiment Videos

Last Updated: Mar 5, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

6.8K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K

Articles linked to this work by shared authors, journal, and citation graph.

Intersectionality in AI and Machine Learning for Health Care: Protocol for a Scoping Review.

JMIR research protocols·2026

Budesonide in Liver Transplant Recipients requiring Long-term Corticosteroid in Maintenance Immunosuppression: A Retrospective Case Series.

Transplantation proceedings·2026

A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper.

Hepatology international·2026

Artificial intelligence predicts recurrent autoimmune hepatitis after liver transplantation in a multicenter cohort study.

Hepatology communications·2026

Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment.

Clinical and molecular hepatology·2026

Third annual transplant AI symposium: from organ matching to digital twins.

Frontiers in transplantation·2026

Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study.

Journal of hepatology·2026

EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.

Journal of hepatology·2026

Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.

Journal of hepatology·2026

Overall and Line-Specific Impact of Targeted Therapies in Advanced Biliary Tract Cancer After Chemoimmunotherapy Failure.

Journal of hepatology·2026

EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance.

Journal of hepatology·2026

Restoration of aged liver regeneration by youthful systemic factors via LTβ-driven hepatocyte reprogramming.

Journal of hepatology·2026

Melanoma Recurrence Prediction Using a Tissue-Free Epigenomic Molecular Residual Disease Assay: a Multicenter Prospective Observational Study (COSMOS-MEL01).

Cancer research communications·2026

TCF4-driven cathepsin S promotes papillary thyroid carcinoma via PI3K/AKT/mTOR.

Endocrine-related cancer·2026

Risk factors for subsequent thyroid neoplasms development in childhood cancer survivors.

Endocrine-related cancer·2026

Trends in Location of Death for Individuals with Primary Ocular Cancer in the United States.

Ophthalmic epidemiology·2026

Prognostic Value of Intraoperative Desmopressin Test for Long-Term Remission in Cushing's Disease: A Prospective Cohort Study.

Neurosurgery·2026

Primary Tumor Histologic Regression and Immunotherapy Outcomes in Recurrent or Metastatic Melanoma.

Cancer investigation·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us